Add like
Add dislike
Add to saved papers

Prognostic Implications of Premature Ventricular Contractions and Non-sustained Ventricular Tachycardia in Light-Chain Cardiac Amyloidosis.

BACKGROUND AND AIMS: Premature ventricular contractions (PVC) and non-sustained ventricular tachycardia (NSVT) are commonly observed in light chain cardiac amyloidosis (AL-CA), but their association with prognosis is still unclear. We aimed to evaluate the prognostic value of PVCs and NSVT in patients with moderate-to-advanced AL-CA.

METHODS: We retrospectively included patients with AL-CA at modified 2004 Mayo stages II-IIIb between February 2014 and December 2020. Twenty-four-hour Holter recordings were assessed on admission. The outcomes included 1) new onset of adverse ventricular arrhythmia (VA) or SCD and 2) cardiac death during follow-up.

RESULTS: Of the 143 patients studied (60.4±11.1 years, male 64.3%), 132 (92.3%) had presence of PVC and 50 (35.0%) had NSVT on Holter. Twelve (8.4%) patients died in hospital and 131 patients were followed up (median 24.4 months), among whom 71 patients had cardiac death, 15 underwent adverse VA/SCD. NSVT [HR: 13.57, 95% CI: 3.06-60.18, p<0.001], log-transformed PVC counts (HR:1.46,95%CI:1.15-1.86, p=0.002) and PVC burden (HR:1.43 95%CI:1.14-1.80, p=0.002) were predictive of new onset of adverse VA/SCD. The highest tertile of PVC counts (HR: 2.33, 95%CI: 1.27-4.28, p=0.006) and PVC burden (HR: 2.58, 95%CI: 1.42-4.69, p=0.002), rather than NSVT (HR:1.16, 95%CI: 0.67-1.98, p=0.603), was associated with cardiac death. Higher PVC counts/burden provided incremental value on modified 2004 Mayo stage in predicting cardiac death, with C index increasing from 0.681 to 0.712 and 0.717, respectively (p values <0.05).

CONCLUSIONS: PVC count, burden and NSVT significantly correlated with adverse VA/SCD during follow-up in patients with AL-CA. Higher PVC counts/burden added incremental value for predicting cardiac death.

Full text links

We have located open access text paper links.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app